London Project to Cure Blindness begins clinical trial of stem cell treatment for wet AMD

A clinical trial of a stem cell transplantation treatment for wet age-related macular degeneration is underway after the first patient had a successful surgery, according to a Moorfields Eye Hospital press release.The trial is part of the London Project to Cure Blindness, a partnership among the hospital, the UCL Institute of Ophthalmology, the National Institute for Health Research and Pfizer. It is investigating the safety and stability of transplanted retinal pigment epithelium cells and whether there is an effect in restoring vision in 10 wet AMD patients over an 18-month period.